|
TIDMABC
RNS Number : 9871Q
ABCAM Plc
27 October 2011
For immediate release 27 October 2011
ABCAM PLC
("Abcam" or "the Company")
Director/PDMR dealing: Share Incentive Plan
Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of protein research tools, has today been notified of the following transactions under the Abcam plc Share Incentive Plan to the benefit of the Executive Directors and PDMRs in line with the regular annual invitation to participate:
Name Partnership Matching Shares Free Shares
Shares purchased awarded on awarded on
on 26 October 26 October 26 October
2011 at 344.78p 2011 at 344.78p 2011 at 344.78p
per 0.2 pence per 0.2 pence per 0.2 pence
Ordinary Share Ordinary Share Ordinary Share
---------------------- ----------------- ------------------ ----------------- -----------------
Executive Directors: Jonathan Milner 436 436 870
---------------------- ----------------- ------------------ ----------------- -----------------
Jeff Iliffe 436 436 870
---------------------------------------- ------------------ ----------------- -----------------
Jim Warwick 436 436 870
---------------------------------------- ------------------ ----------------- -----------------
PDMRs: Mark Bushfield 217 217 870
---------------------- ----------------- ------------------ ----------------- -----------------
Jane Cooke - - 870
---------------------------------------- ------------------ ----------------- -----------------
Philippe Cotrel 217 217 870
---------------------------------------- ------------------ ----------------- -----------------
Ed Ralph 435 435 870
---------------------------------------- ------------------ ----------------- -----------------
The risk of forfeiture attached to the Matching Shares will normally be removed on the third anniversary of the award subject to continued employment and the retention of the Partnership Shares in connection with which they were awarded. The risk of forfeiture attached to the Free Shares will normally be removed on the third anniversary of the award subject to continued employment.
No consideration was paid by the above grantees for the award of the Matching and Free Shares and no consideration is due on the release of these shares.
For further information please contact:
Abcam + 44 (0) 1223 696000
Jonathan Milner, Chief Executive Officer
Jeff Iliffe, Chief Financial Officer
www.abcamplc.com
Numis Securities + 44 (0) 20 7260 1000
Michael Meade / Nick Westlake - Nominated
Adviser
James Black - Corporate Broking
Buchanan Communications + 44 (0) 20 7466 5000
Mark Court / Jessica Fontaine
Notes for editors:
About Abcam plc
Abcam is a producer and distributor of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level, which is essential in understanding health and disease.
Headquartered in Cambridge (UK), Abcam has subsidiary offices in Bristol (UK), Cambridge, MA (USA), Eugene, OR (USA), Tokyo (Japan) and Hong Kong (China) allowing it to serve a global customer base in over 85 countries. Abcam employs over 325 staff across its six operating companies.
Abcam now has an online catalogue of over 80,000 products sourced from over 300 suppliers. The catalogue includes a growing range of non-primary antibody products such as secondaries, proteins, peptides, lysates, immunoassays and other kits. Products are available for life science research and distributed to academic and commercial users. A highly developed eCommerce platform, which includes regional websites for the Chinese and Japanese markets, allows customers to access up-to-date and detailed technical product data sheets at the Company's website www.abcam.com.
Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company's vision is to be the leading provider of protein research tools globally.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSZDLFLFBFXFBF
| 
